COVID-19 research opens to little-studied group: Pregnant patients Penn In the News The Wall Street Journal COVID-19 research opens to little-studied group: Pregnant patients Katharine Bar and Michal Elovitz of the Perelman School of Medicine are opening the COVID-19 convalescent-plasma trials they’re conducting to pregnant people. “If we don’t enroll them in trials, we won’t have therapies for them when they are sick,” said Bar. LGBTQ data added to the state’s COVID-19 testing LGBTQ data added to the state’s COVID-19 testing Experts weigh in on the state’s decision to add LGBTQ data collection to COVID-19 testing. Pennsylvania Governor Tom Wolf announced on March 13 that the state will include LGBTQ-specific information as part of its COVID-19 data collection. Florida, Arizona and Texas report record number of daily COVID-19 cases this week Penn In the News CNN Florida, Arizona and Texas report record number of daily COVID-19 cases this week Research from CHOP's PolicyLab, led by David Rubin, Gregory Tasian, and Jing Huang of the Perelman School of Medicine, has found that the coronavirus seems to be following highways as it spreads. Additional challenges in bringing research online The Devlin lab are working on creating an extremely cold environment (nearly -460 degrees Fahrenheit) so that the new Simons Observatory can detect cosmic microwave background (CMB), the residual radiation left behind by the Big Bang. Work done at the High Bay is essential for keeping the project from falling further behind after shutdown delays. nocred Additional challenges in bringing research online As research on campus slowly restarts, those whose work requires field surveys, large-scale collaborations, or travel face additional challenges in bringing their research back online. Researchers analyze ethics of allocating medical resources in COVID-19 Researchers analyze ethics of allocating medical resources in COVID-19 The COVID-19 pandemic has left many health care providers scrambling for resources to treat cases over the last several months, making doctors face difficult decisions: Whom do you save? Building capacity to combat COVID-19 in Africa Building capacity to combat COVID-19 in Africa Wharton School students, along with the Zicklin Center for Business Ethics Research, are issuing a call for proposals for a new initiative designed to aid in the fight against the coronavirus. FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring Penn In the News Philadelphia Inquirer FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring Carl June of the Perelman School of Medicine is leading a study investigating the effects of cyclosporine on calming the immune systems of COVID-19 patients to prevent cytokine storms. Monster or machine? A profile of the coronavirus at 6 months Penn In the News The New York Times Monster or machine? A profile of the coronavirus at 6 months Susan R. Weiss of the Perelman School of Medicine spoke about coronavirology and the uptick in interest in the field. Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Penn In the News Science Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Nilam Mangalmurti of the Perelman School of Medicine said the way COVID-19 attacks blood vessels in the lungs, causing inflammation throughout the body and fueling additional respiratory problems, is “a vicious cycle.” A possible link between certain psoriasis treatments and respiratory-tract infection risk A possible link between certain psoriasis treatments and respiratory-tract infection risk After examining data from large trials of autoimmune-disease medications called Interleukin-17 inhibitors, researchers found individuals who took these treatments were more likely to develop symptoms associated with respiratory-tract infections. Load More
LGBTQ data added to the state’s COVID-19 testing LGBTQ data added to the state’s COVID-19 testing Experts weigh in on the state’s decision to add LGBTQ data collection to COVID-19 testing. Pennsylvania Governor Tom Wolf announced on March 13 that the state will include LGBTQ-specific information as part of its COVID-19 data collection.
Florida, Arizona and Texas report record number of daily COVID-19 cases this week Penn In the News CNN Florida, Arizona and Texas report record number of daily COVID-19 cases this week Research from CHOP's PolicyLab, led by David Rubin, Gregory Tasian, and Jing Huang of the Perelman School of Medicine, has found that the coronavirus seems to be following highways as it spreads. Additional challenges in bringing research online The Devlin lab are working on creating an extremely cold environment (nearly -460 degrees Fahrenheit) so that the new Simons Observatory can detect cosmic microwave background (CMB), the residual radiation left behind by the Big Bang. Work done at the High Bay is essential for keeping the project from falling further behind after shutdown delays. nocred Additional challenges in bringing research online As research on campus slowly restarts, those whose work requires field surveys, large-scale collaborations, or travel face additional challenges in bringing their research back online. Researchers analyze ethics of allocating medical resources in COVID-19 Researchers analyze ethics of allocating medical resources in COVID-19 The COVID-19 pandemic has left many health care providers scrambling for resources to treat cases over the last several months, making doctors face difficult decisions: Whom do you save? Building capacity to combat COVID-19 in Africa Building capacity to combat COVID-19 in Africa Wharton School students, along with the Zicklin Center for Business Ethics Research, are issuing a call for proposals for a new initiative designed to aid in the fight against the coronavirus. FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring Penn In the News Philadelphia Inquirer FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring Carl June of the Perelman School of Medicine is leading a study investigating the effects of cyclosporine on calming the immune systems of COVID-19 patients to prevent cytokine storms. Monster or machine? A profile of the coronavirus at 6 months Penn In the News The New York Times Monster or machine? A profile of the coronavirus at 6 months Susan R. Weiss of the Perelman School of Medicine spoke about coronavirology and the uptick in interest in the field. Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Penn In the News Science Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Nilam Mangalmurti of the Perelman School of Medicine said the way COVID-19 attacks blood vessels in the lungs, causing inflammation throughout the body and fueling additional respiratory problems, is “a vicious cycle.” A possible link between certain psoriasis treatments and respiratory-tract infection risk A possible link between certain psoriasis treatments and respiratory-tract infection risk After examining data from large trials of autoimmune-disease medications called Interleukin-17 inhibitors, researchers found individuals who took these treatments were more likely to develop symptoms associated with respiratory-tract infections. Load More
Additional challenges in bringing research online The Devlin lab are working on creating an extremely cold environment (nearly -460 degrees Fahrenheit) so that the new Simons Observatory can detect cosmic microwave background (CMB), the residual radiation left behind by the Big Bang. Work done at the High Bay is essential for keeping the project from falling further behind after shutdown delays. nocred Additional challenges in bringing research online As research on campus slowly restarts, those whose work requires field surveys, large-scale collaborations, or travel face additional challenges in bringing their research back online.
Researchers analyze ethics of allocating medical resources in COVID-19 Researchers analyze ethics of allocating medical resources in COVID-19 The COVID-19 pandemic has left many health care providers scrambling for resources to treat cases over the last several months, making doctors face difficult decisions: Whom do you save?
Building capacity to combat COVID-19 in Africa Building capacity to combat COVID-19 in Africa Wharton School students, along with the Zicklin Center for Business Ethics Research, are issuing a call for proposals for a new initiative designed to aid in the fight against the coronavirus.
FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring Penn In the News Philadelphia Inquirer FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring Carl June of the Perelman School of Medicine is leading a study investigating the effects of cyclosporine on calming the immune systems of COVID-19 patients to prevent cytokine storms. Monster or machine? A profile of the coronavirus at 6 months Penn In the News The New York Times Monster or machine? A profile of the coronavirus at 6 months Susan R. Weiss of the Perelman School of Medicine spoke about coronavirology and the uptick in interest in the field. Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Penn In the News Science Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Nilam Mangalmurti of the Perelman School of Medicine said the way COVID-19 attacks blood vessels in the lungs, causing inflammation throughout the body and fueling additional respiratory problems, is “a vicious cycle.” A possible link between certain psoriasis treatments and respiratory-tract infection risk A possible link between certain psoriasis treatments and respiratory-tract infection risk After examining data from large trials of autoimmune-disease medications called Interleukin-17 inhibitors, researchers found individuals who took these treatments were more likely to develop symptoms associated with respiratory-tract infections. Load More
Monster or machine? A profile of the coronavirus at 6 months Penn In the News The New York Times Monster or machine? A profile of the coronavirus at 6 months Susan R. Weiss of the Perelman School of Medicine spoke about coronavirology and the uptick in interest in the field. Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Penn In the News Science Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Nilam Mangalmurti of the Perelman School of Medicine said the way COVID-19 attacks blood vessels in the lungs, causing inflammation throughout the body and fueling additional respiratory problems, is “a vicious cycle.” A possible link between certain psoriasis treatments and respiratory-tract infection risk A possible link between certain psoriasis treatments and respiratory-tract infection risk After examining data from large trials of autoimmune-disease medications called Interleukin-17 inhibitors, researchers found individuals who took these treatments were more likely to develop symptoms associated with respiratory-tract infections. Load More
Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Penn In the News Science Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ Nilam Mangalmurti of the Perelman School of Medicine said the way COVID-19 attacks blood vessels in the lungs, causing inflammation throughout the body and fueling additional respiratory problems, is “a vicious cycle.” A possible link between certain psoriasis treatments and respiratory-tract infection risk A possible link between certain psoriasis treatments and respiratory-tract infection risk After examining data from large trials of autoimmune-disease medications called Interleukin-17 inhibitors, researchers found individuals who took these treatments were more likely to develop symptoms associated with respiratory-tract infections.
A possible link between certain psoriasis treatments and respiratory-tract infection risk A possible link between certain psoriasis treatments and respiratory-tract infection risk After examining data from large trials of autoimmune-disease medications called Interleukin-17 inhibitors, researchers found individuals who took these treatments were more likely to develop symptoms associated with respiratory-tract infections.